Your browser doesn't support javascript.
loading
Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning.
Echle, Amelie; Grabsch, Heike Irmgard; Quirke, Philip; van den Brandt, Piet A; West, Nicholas P; Hutchins, Gordon G A; Heij, Lara R; Tan, Xiuxiang; Richman, Susan D; Krause, Jeremias; Alwers, Elizabeth; Jenniskens, Josien; Offermans, Kelly; Gray, Richard; Brenner, Hermann; Chang-Claude, Jenny; Trautwein, Christian; Pearson, Alexander T; Boor, Peter; Luedde, Tom; Gaisa, Nadine Therese; Hoffmeister, Michael; Kather, Jakob Nikolas.
Afiliação
  • Echle A; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Grabsch HI; Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands; Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Quirke P; Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • van den Brandt PA; Department of Epidemiology, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • West NP; Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Hutchins GGA; Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Heij LR; Visceral and Transplant Surgery, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany; NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands; Institute of Pathology, University Hospital RWTH Aachen,
  • Tan X; Visceral and Transplant Surgery, University Hospital Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany; NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands; Institute of Pathology, University Hospital RWTH Aachen,
  • Richman SD; Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Krause J; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Alwers E; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
  • Jenniskens J; Department of Epidemiology, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Offermans K; Department of Epidemiology, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Gray R; Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom.
  • Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany; German Cancer Consortium, German Cancer Research Center, Heidelberg, G
  • Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; Cancer Epidemiology Group, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Trautwein C; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
  • Pearson AT; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Boor P; Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
  • Luedde T; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany; Division of Gastroenterology, Hepatology, and Hepatobiliary Oncology, Aachen, Germany.
  • Gaisa NT; Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
  • Hoffmeister M; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
  • Kather JN; Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany; Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany; Medical Oncology, N
Gastroenterology ; 159(4): 1406-1416.e11, 2020 10.
Article em En | MEDLINE | ID: mdl-32562722
BACKGROUND & AIMS: Microsatellite instability (MSI) and mismatch-repair deficiency (dMMR) in colorectal tumors are used to select treatment for patients. Deep learning can detect MSI and dMMR in tumor samples on routine histology slides faster and less expensively than molecular assays. However, clinical application of this technology requires high performance and multisite validation, which have not yet been performed. METHODS: We collected H&E-stained slides and findings from molecular analyses for MSI and dMMR from 8836 colorectal tumors (of all stages) included in the MSIDETECT consortium study, from Germany, the Netherlands, the United Kingdom, and the United States. Specimens with dMMR were identified by immunohistochemistry analyses of tissue microarrays for loss of MLH1, MSH2, MSH6, and/or PMS2. Specimens with MSI were identified by genetic analyses. We trained a deep-learning detector to identify samples with MSI from these slides; performance was assessed by cross-validation (N = 6406 specimens) and validated in an external cohort (n = 771 specimens). Prespecified endpoints were area under the receiver operating characteristic (AUROC) curve and area under the precision-recall curve (AUPRC). RESULTS: The deep-learning detector identified specimens with dMMR or MSI with a mean AUROC curve of 0.92 (lower bound, 0.91; upper bound, 0.93) and an AUPRC of 0.63 (range, 0.59-0.65), or 67% specificity and 95% sensitivity, in the cross-validation development cohort. In the validation cohort, the classifier identified samples with dMMR with an AUROC of 0.95 (range, 0.92-0.96) without image preprocessing and an AUROC of 0.96 (range, 0.93-0.98) after color normalization. CONCLUSIONS: We developed a deep-learning system that detects colorectal cancer specimens with dMMR or MSI using H&E-stained slides; it detected tissues with dMMR with an AUROC of 0.96 in a large, international validation cohort. This system might be used for high-throughput, low-cost evaluation of colorectal tissue specimens.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Neoplásicas Hereditárias / Neoplasias Encefálicas / Neoplasias Colorretais / Instabilidade de Microssatélites / Aprendizado Profundo Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Neoplásicas Hereditárias / Neoplasias Encefálicas / Neoplasias Colorretais / Instabilidade de Microssatélites / Aprendizado Profundo Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha